Inpharma Weekly

, Volume 1248, Issue 1, pp 16–16 | Cite as

Docetaxel is active in patients with unresectable metastatic or locally advanced pancreatic cancer,

Clinical study
  • 3 Downloads

Keywords

Adenocarcinoma Pancreatic Cancer Neutropenia Docetaxel Partial Response 

Copyright information

© Adis International Ltd 2000

Personalised recommendations